Approval regulation and endogenous consumer confidence: Theory and analogies to licensing, safety, and financial regulation

Regulation and Governance

Volumn 4, Issue 4, 2010, Pages 383-407

  Carpenter, Daniel ^a   Grimmer, Justin ^b   Lomazoff, Eric ^a  

^a HARVARD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Approval regulation; Financial regulation; Licensing; Pharmaceuticals; Safety regulation

Indexed keywords

EID: 78649560865     PISSN: 17485983     EISSN: 17485991     Source Type: Journal    
DOI: 10.1111/j.1748-5991.2010.01091.x     Document Type: Article

References (32)

1. Alt J, Calvert R, Humes B (1988) Reputation and Hegemonic Stability: A Game-theoretic Analysis. American Political Science Review 82, 445-466.
2. Avorn J (2004) Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs. Knopf, New York, NY.
3. Banks JS, Sundaram R (1994) Switching Costs and the Gittins Index. Econometrica 62, 687-694.
4. Billingsley P (1999) Convergence of Probability Measures, 2nd edn. Wiley, New York, NY.
5. Boardman AE, Greenberg DH, Vining AR, Weimer DL (1996) Cost-Benefit Analysis: Concepts and Practice. Prentice Hall, Upper Saddle River, NJ.
6. Bollinger B, Leslie P, Sorensen A (2010) Calorie Posting in Chain Restaurants. Working Paper, Stanford University. Stanford, CA.
7. Calvert R (1987) Reputation and Legislative Leadership. Public Choice 55, 81-119.
8. Candell LN (2010) What the Financial Sector Should Borrow: A Military Approach to Keeping the Economy Safe. Harvard Business Review 88(1), 46-48.
9. Carpenter D (2004) Protection without Capture: Product Approval by a Politically Responsive, Learning Regulator. American Political Science Review 98(4), 613-631.
10. Carpenter D (2010) Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA. Princeton University Press, Princeton, NJ.
11. Carpenter D, Ting MM (2007) Regulatory Errors with Endogenous Agendas. American Journal of Political Science 51(4), 835-853.
12. Chernoff H (1968) Optimal Stochastic Control. Sankhya - The Indian Journal of Statistics Series A 30(3), 221-252.
13. Dixit A, Pindyck R (1994) Investment Under Uncertainty. Princeton University Press, Princeton, NJ.
14. Eisenberg R (2007) The Role of the FDA in Innovation Policy. Michigan Telecommunications and Technology Law Review 13(1), 345-388.
15. Hamilton A (2001 17691804) Writings. Ed. Joanne Freeman, The Library of America, New York.
16. Jin G, Leslie P (2003) The Effect of Information on Product Quality: Evidence from Restaurant Hygiene Grade Cards. Quarterly Journal of Economics 118(2), 409-451.
17. Jovanovic B (October 1979) Job Matching and the Theory of Turnover. Journal of Political Economy 87(5), 972-990.
18. Karatzas I (1984) Gittins Indices in the Dynamic Allocation Problem for Diffusion Processes. The Annals of Probability 12(1), 173-192.
19. Karatzas I, Shreve S (1991) Brownian Motion and Stochastic Calculus, 2nd edn. Springer-Verlag, New York, NY.
20. Katz A (2007) Pharmaceutical Lemons: Innovation and Regulation in the Drug Industry. Michigan Telecommunications and Technology Law Review 14(1), 1-41.
21. Laffont JJ, Tirole J (1994) A Theory of Incentives in Regulation and Procurement. MIT Press, Cambridge, MA.
22. Law M (2003) The Origins of State Pure Food Regulation. Journal of Economic History 63(4), 1103-1130.
23. Law M (2006) How Do Regulators Regulate? Enforcement of the Pure Food and Drugs Act, 1907-38. Journal of Law, Economics, and Organization 22(2), 459-489.
24. Law M, Kim S (2005) Specialization and Regulation: The Rise of Professionals and the Emergence of Occupational Licensing Regulation. Journal of Economic History 65(3), 723-756.
25. Law M, Marks MS (2009) The Effects of Occupational Licensing Laws on Minorities: Evidence from the Progressive Era. Journal of Law and Economics 52(2), 351-366.
26. Mandelbaum A (1987) Continuous Multi-armed Bandits and Multiparameter Processes. The Annals of Probability 15(4), 1527-1556.
27. Manski C (2009) Adaptive Partial Drug Approval: A Policy Proposal. The Economist's Voice 6(4). [Last accessed 27 Sep 2010.] Available from URL:
28. Peltzman S (1976) Regulation of Pharmaceutical Innovation: The 1962 Amendments. American Enterprise Institute, Washington, DC.
29. Stiglitz J (2008) The Financial Crisis of 2007/2008 and Its Macroeconomic Consequences. Working Paper, Columbia University.
30. Viscusi WK (1993) The Value of Risks to Life and Health. Journal of Economic Literature 31(4), 1912-1946.
31. Warren E (2007) Unsafe at Any Rate. Democracy: A Journal of Ideas. Issue 5, Summer 2007.
32. Warren E (2008) Product Safety Regulation as a Model for Financial Services Regulation. The Journal of Consumer Affairs 42(3), 452-460.